The Mechanistic Biology of Primary Immunodeficiency Disorders | MicrobiomeTrials← Back to trialsNCT03394053
The Mechanistic Biology of Primary Immunodeficiency Disorders
RecruitingOBSERVATIONAL
Trial Details
Start: 2018-05-30Est. Completion: 2029-12-31
Enrollment target: 2,500 participants Locations- Children's National Health System (CNHS), Washington D.C., District of Columbia, United States
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Other microbiome trials you might be interested in
HivOpioid Use
The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in th…
New Haven, United StatesEst. completion Dec 2028
Genetic DiseaseImmune DysfunctionNeurological Diseases or ConditionsAutoimmune Diseases
Type I interferonopathies are rare autoinflammatory disorders caused by genetic defects and associated with significant …
Innsbruck, AustriaEst. completion Oct 2045
Recruiting
This study seeks to develop an RS-ART implementation strategy by utilizing the Delphi method and interviewing experts an…
Kajang, MalaysiaEst. completion May 2028